32.26
                                            Schlusskurs vom Vortag:
              $32.04
            Offen:
              $32
            24-Stunden-Volumen:
                21,211
            Relative Volume:
              1.42
            Marktkapitalisierung:
                $N/A
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              +5.53%
            1M Leistung:
              +18.19%
            6M Leistung:
                +68.98%
            1J Leistung:
              +13.47%
            Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Firmenname
                  
                      Virtus Lifesci Biotech Clinical Trials Etf
                    
                Sektor
                  Branche
                  Telefon
                  
                      -
                    
                Adresse
                  
                      -
                    
                Vergleichen Sie BBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                BBC
                            
                             Virtus Lifesci Biotech Clinical Trials Etf | 32.26 | 0 | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VTI
                            
                             Vanguard Total Stock Market Etf | 335.42 | 417.53B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                SPY
                            
                             Spdr S P 500 Etf Trust | 682.06 | 372.57B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                IVV
                            
                             Ishares Core S P 500 Etf | 685.23 | 253.41B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VB
                            
                             Vanguard Small Cap Etf | 254.99 | 160.59B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                QQQ
                            
                             Invesco Qqq Trust Series 1 | 629.07 | 124.43B | 0 | 0 | 0 | 0.00 | 
Virtus Lifesci Biotech Clinical Trials Etf Aktie (BBC) Neueste Nachrichten
Biotech ETF (BBC) Hits New 52-Week High - MSN
Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock price, news, quote and history - Yahoo! Finance UK
Biotech ETFs Hovering Around a 52-Week: Here's Why - Nasdaq
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Can Virtus LifeSci Biotech Clinical Trials stock deliver strong annual returns2025 Pullback Review & Fast Entry Momentum Alerts - nchmf.gov.vn
Discipline and Rules-Based Execution in BBC Response - news.stocktradersdaily.com
Trade War or Not, Specific Industry ETFs Are in Sweet Spots - TradingView
What MACD trends signal for Virtus LifeSci Biotech Clinical Trials stockWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Will Virtus LifeSci Biotech Clinical Trials stock return to pre crash levelsMarket Movers & Proven Capital Preservation Methods - newser.com
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC - sharewise.com
Best-Performing ETFs of Last Week - sharewise.com
Canadian Equities Shine: ETFs to Capture the Momentum - The Globe and Mail
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
(BBC) Trading Signals - news.stocktradersdaily.com
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
Wall Street Week Ahead - Seeking Alpha
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - Nasdaq
Virtus LifeSci Biotech Clinical Trials ETF (BBC) Stock Trends and Sentiment 2025 - MarketBeat
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ALPS’ Biotech ETF SBIO Week's Top Performer - ETF Trends
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal - ETF Trends
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Zacks Investment Research
Biotech ETFs Are Making a Comeback - ETF Trends
Biotech ETF Tops in June: 5 Stocks That Outperform - Zacks Investment Research
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point - ETF Trends
How to Pick a Biotech ETF - Investment U
Positioning for Biotech Bounceback - ETF Trends
Make Biotech Cash Considerations With SBIO - ETF Trends
Some Biotech Stocks Are Now Cheap - ETF Trends
Biotech M&A Could Finally Perk Up in 2022 - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
Biotech Stocks Have Colds, but They Can Heal - ETF Trends
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - ETF.com
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Nasdaq
Finanzdaten der Virtus Lifesci Biotech Clinical Trials Etf-Aktie (BBC)
        Es liegen keine Finanzdaten für Virtus Lifesci Biotech Clinical Trials Etf (BBC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App